Orange Book product
LITHIUM CITRATE EQ 300MG CARBONATE/5ML
Orange Book ANDA 218036 · RUBICON RESEARCH LTD · Prescription
Key facts
| Proprietary name | LITHIUM CITRATE |
|---|---|
| Active ingredients | LITHIUM CITRATE |
| Strength | EQ 300MG CARBONATE/5ML |
| Dosage form | SYRUP |
| Route | ORAL |
| Application | ANDA218036 |
| Applicant holder | RUBICON RESEARCH LTD |
| Marketing status | Prescription |
| Therapeutic equivalence (TE) code | AA |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | Yes |
| Approval date | Aug 14, 2023 |
At a glance
- 1–9 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.